[{"address1": "777 W 41st St.", "city": "Miami Beach", "state": "FL", "zip": "33140", "country": "United States", "phone": "605 679 6980", "website": "https://www.sabbiotherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders. It has applied advanced genetic engineering to develop transchromosomic for hyperimmunization and plasma collection, as well as develops product to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders. In addition, its lead product candidate SAB-142, a human, multi-target anti-thymocyte globulin treatment, currently under Phase 2b clinical trials in delaying the onset or progression of type 1. SAB Biotherapeutics, Inc. was founded in 2014 and is headquartered in Miami Beach, Florida.", "fullTimeEmployees": 63, "companyOfficers": [{"maxAge": 1, "name": "Mr. Samuel J. Reich", "age": 49, "title": "Chairman & CEO", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 782100, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Eddie Joe Sullivan Ph.D.", "age": 58, "title": "Co-Founder, President & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 744382, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lucy  To", "age": 38, "title": "Executive VP & CFO", "yearBorn": 1986, "fiscalYear": 2024, "totalPay": 380659, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christoph  Bausch M.B.A., Ph.D.", "age": 53, "title": "Executive VP & COO", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 574585, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alexandra  Kropotova M.B.A., M.D.", "age": 51, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 790150, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Catherine  DeRose", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hua  Wu Ph.D.", "title": "Senior Vice President of Product Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Carlos N. Carillo M.Sc., Ph.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angie  Parizek", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.04, "open": 4.08, "dayLow": 3.93, "dayHigh": 4.18, "regularMarketPreviousClose": 4.04, "regularMarketOpen": 4.08, "regularMarketDayLow": 3.93, "regularMarketDayHigh": 4.18, "payoutRatio": 0.0, "beta": 0.612, "forwardPE": -1.4416058, "volume": 232526, "regularMarketVolume": 232526, "averageVolume": 307968, "averageVolume10days": 237100, "averageDailyVolume10Day": 237100, "bid": 3.9, "ask": 4.01, "bidSize": 1, "askSize": 1, "marketCap": 188047072, "fiftyTwoWeekLow": 1.0, "fiftyTwoWeekHigh": 6.6, "allTimeHigh": 129.0, "allTimeLow": 1.0, "priceToSalesTrailing12Months": 1639.4974, "fiftyDayAverage": 2.8864, "twoHundredDayAverage": 2.13716, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 83353840, "profitMargins": 163.38321, "floatShares": 22589927, "sharesOutstanding": 47606851, "sharesShort": 676534, "sharesShortPriorMonth": 692718, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.014199999, "heldPercentInsiders": 0.12367, "heldPercentInstitutions": 0.59258, "shortRatio": 2.77, "shortPercentOfFloat": 0.0148, "impliedSharesOutstanding": 47606851, "bookValue": 3.476, "priceToBook": 1.1363636, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -4288005, "trailingEps": -1.56, "forwardEps": -2.74, "lastSplitFactor": "1:10", "lastSplitDate": 1704412800, "enterpriseToRevenue": 726.724, "enterpriseToEbitda": -2.079, "52WeekChange": 0.405694, "SandP52WeekChange": 0.1326145, "quoteType": "EQUITY", "currentPrice": 3.95, "targetHighPrice": 14.0, "targetLowPrice": 5.0, "targetMeanPrice": 8.83333, "targetMedianPrice": 8.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 110880632, "totalCashPerShare": 2.329, "ebitda": -40087972, "totalDebt": 6187342, "quickRatio": 10.325, "currentRatio": 10.495, "totalRevenue": 114698, "debtToEquity": 3.748, "revenuePerShare": 0.012, "returnOnAssets": -0.22757, "returnOnEquity": 0.18556, "grossProfits": -30333560, "freeCashflow": -20132516, "operatingCashflow": -37530972, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -376.5713, "financialCurrency": "USD", "symbol": "SABS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "SAB Biotherapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612881000000, "postMarketChangePercent": 0.25316432, "postMarketPrice": 3.96, "postMarketChange": 0.00999999, "regularMarketChange": -0.0899999, "regularMarketDayRange": "3.93 - 4.18", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 307968, "fiftyTwoWeekLowChange": 2.95, "fiftyTwoWeekLowChangePercent": 2.95, "fiftyTwoWeekRange": "1.0 - 6.6", "fiftyTwoWeekHighChange": -2.6499999, "fiftyTwoWeekHighChangePercent": -0.40151513, "fiftyTwoWeekChangePercent": 40.5694, "earningsTimestampStart": 1754510400, "earningsTimestampEnd": 1754942400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.56, "epsForward": -2.74, "epsCurrentYear": -1.0, "priceEpsCurrentYear": -3.95, "fiftyDayAverageChange": 1.0636001, "fiftyDayAverageChangePercent": 0.36848673, "twoHundredDayAverageChange": 1.81284, "twoHundredDayAverageChangePercent": 0.8482472, "corporateActions": [], "postMarketTime": 1764362753, "regularMarketTime": 1764352800, "exchange": "NCM", "messageBoardId": "finmb_268941400", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -2.22772, "regularMarketPrice": 3.95, "longName": "SAB Biotherapeutics, Inc.", "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "displayName": "SAB Biotherapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-29"}]